Cargando…

Haematological Findings in African Children in Uganda with Malignant Lymphoma

Detalles Bibliográficos
Autor principal:	Stansfield, D.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1961
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2071110/ https://www.ncbi.nlm.nih.gov/pubmed/21772446

Ejemplares similares

Hodgkin lymphoma detection and survival: findings from the Haematological Malignancy Research Network
por: Lamb, Maxine JE, et al.
Publicado: (2019)

Breast imaging findings in haematological malignancies
por: Glazebrook, K. N., et al.
Publicado: (2014)

COVID-19 in children with haematological malignancies
por: Millen, Gerard Cathal, et al.
Publicado: (2022)

Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network
por: Smith, A, et al.
Publicado: (2011)

Survival of critically ill patients with haematological malignancies compared with patients without haematological malignancy
por: Pugh, R, et al.
Publicado: (2013)

PSYCHOLOGICAL ASPECTS OF HAEMATOLOGICAL MALIGNANCIES
por: Kulhara, P., et al.
Publicado: (1990)

Tuberculosis in Patients with Haematological Malignancies
por: Anibarro, Luis, et al.
Publicado: (2014)

BURDEN OF CARE IN PATENTS OF CHILDREN SUFFERING FROM HAEMATOLOGICAL MALIGNANCIES
por: Kulhara, Parmanand, et al.
Publicado: (1998)

BURDEN OF CARE IN PARENTS OF CHILDREN SUFFERING FROM HAEMATOLOGICAL MALIGNANCIES
por: Ashok, M.V., et al.
Publicado: (1998)

Expression of testicular genes in haematological malignancies
por: Lim, S H, et al.
Publicado: (1999)

The Role of miRNA in Haematological Malignancy
por: Gounaris-Shannon, Stephanie, et al.
Publicado: (2013)

Extended haematological follow-up after parenteral artesunate in African children with severe malaria
por: Rolling, Thierry, et al.
Publicado: (2012)

Clinical use of rituximab in haematological malignancies
por: Avivi, I, et al.
Publicado: (2003)

Cancer stem cells in haematological malignancies
por: Zagozdzon, Radoslaw, et al.
Publicado: (2015)

The hypoxia signalling pathway in haematological malignancies
por: Irigoyen, Marta, et al.
Publicado: (2017)

The Application of CAR-T Cells in Haematological Malignancies
por: Skorka, Katarzyna, et al.
Publicado: (2020)

Clinical Proteomics of Biofluids in Haematological Malignancies
por: Dunphy, Katie, et al.
Publicado: (2021)

Targeting hypoxia in solid and haematological malignancies
por: Harris, Bill, et al.
Publicado: (2022)

Immune-epigenetic crosstalk in haematological malignancies
por: Wong, Hera, et al.
Publicado: (2023)

Invasive Fungal Infections in Children with Haematological Malignancies: Diagnostic and Therapeutic Challenges
por: Tragiannidis, Athanasios, et al.
Publicado: (2021)

Preferred and actual place of death in haematological malignancies: a report from the UK haematological malignancy research network
por: Sheridan, Rebecca, et al.
Publicado: (2021)

Severe malnutrition with and without HIV-1 infection in hospitalised children in Kampala, Uganda: differences in clinical features, haematological findings and CD4(+ )cell counts
por: Bachou, Hanifa, et al.
Publicado: (2006)

Time-to-diagnosis and symptoms of myeloma, lymphomas and leukaemias: a report from the Haematological Malignancy Research Network
por: Howell, Debra A, et al.
Publicado: (2013)

Molecular subclusters of follicular lymphoma: a report from the United Kingdom’s Haematological Malignancy Research Network
por: Crouch, Simon, et al.
Publicado: (2022)

Preferred and actual place of death in haematological malignancy
por: Howell, D A, et al.
Publicado: (2017)

Targeting Metabolism and Autophagy in the Context of Haematologic Malignancies
por: Banerji, Versha, et al.
Publicado: (2012)

CAR T Cell Immunotherapy Beyond Haematological Malignancy
por: Hupperetz, Cedric, et al.
Publicado: (2022)

Is intensive care beneficial for patients with haematologic malignancies?
por: Nyunga, M, et al.
Publicado: (2010)

Overview of Histone Deacetylase Inhibitors in Haematological Malignancies
por: Bishton, Mark J., et al.
Publicado: (2010)

Prognosis of patients with haematological malignancies admitted to the ICU
por: Geerse, DA, et al.
Publicado: (2008)

Long Non-Coding RNAs in Haematological Malignancies
por: Garitano-Trojaola, Andoni, et al.
Publicado: (2013)

Serum NMR metabolomics to differentiate haematologic malignancies
por: Wojtowicz, Wojciech, et al.
Publicado: (2018)

Haematological malignancies in Qatar: from childhood to adulthood
Publicado: (2018)

Components of the Lectin Pathway of Complement in Haematologic Malignancies
por: Cedzyński, Maciej, et al.
Publicado: (2020)

PARP Inhibitors and Haematological Malignancies—Friend or Foe?
por: Skelding, Kathryn A., et al.
Publicado: (2021)

Beta-D-Glucan in Patients with Haematological Malignancies
por: Mikulska, Malgorzata, et al.
Publicado: (2021)

PB2363: REPORTING LANGUAGE IN HAEMATOLOGICAL MALIGNANCIES
por: Watt, S., et al.
Publicado: (2022)

Ferroptosis in Haematological Malignancies and Associated Therapeutic Nanotechnologies
por: Mynott, Rachel L., et al.
Publicado: (2023)

Treosulfan for acute myeloid leukaemia and myelodysplastic syndrome in adults, and malignant and non-malignant haematological diseases in children
Publicado: (2023)

Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK's Haematological Malignancy Research Network
por: Smith, A, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qf3i5hghnj7m2p6i2gs9poijvg